🚨 Medistep Healthcare IPO Goes Live at ₹43/Share – Your Portfolio’s Next Lifeline or Just Another Band-Aid?

Healthcare meets hype as Medistep storms the public markets.
The skinny: At ₹43 per share, the IPO’s either a steal or a symptom of sector FOMO—take your pick.
Why it matters: In a market where even stethoscopes get overvalued, Medistep’s pricing walks the tightrope between 'undervalued gem' and 'desperate cash grab.'
Bottom line: Prognosis uncertain. But hey, at least it’s not another meme stock... unless retail gets hold of it.